Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that diphencyprone showed a significant clinical response for treating alopecia areata, while tacrolimus was not effective.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

This study found that immune privilege is preserved in hair follicles of nonsegmental vitiligo patients compared to those with alopecia areata, potentially protecting follicular melanocytes from autoimmune attacks.

This research developed new in vitro models for high-throughput screening of drugs that could protect or restore immune privilege in hair follicles, finding that Tofacitinib was effective in preventing inflammation-related marker upregulation, while Tacrolimus and αMSH worked specifically in outer root sheath keratinocytes.